
Join to View Full Profile
1275 York AveNew York, NY 10021
Phone+1 212-639-7373
Dr. Schoder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 1998 - 2000
- Humboldt University of Berlin - Charite Faculty of MedicineClass of 1989
Certifications & Licensure
- NY State Medical License 2000 - 2026
- CA State Medical License 2000 - 2025
- NJ State Medical License 2006 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
- CBNCNuclear Cardiology
Clinical Trials
- Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors Start of enrollment: 2005 Jun 01
- The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules Start of enrollment: 2004 Mar 01
- The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer Start of enrollment: 2006 Apr 25
- Join now to see all
Publications & Presentations
PubMed
- Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT.Mateus de Oliveira Taveira, Ali Aria Razmaria, Heiko Schoder, Randy Yeh
Journal of Nuclear Medicine. 2025-04-10 - Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma.Magdalena Corona, Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib
Bone Marrow Transplantation. 2025-04-01 - Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.Jae H Park, M Lia Palomba, Karlo Perica, Sean M Devlin, Gunjan Shah
Journal of Clinical Oncology. 2025-01-30
Journal Articles
- CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PETDavid J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood
Abstracts/Posters
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Heiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaHeiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple MyelomaHeiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- The SNMMI and EANM Practice Guideline for Renal Scintigraphy in AdultsAugust 8th, 2018
Grant Support
- Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapySLOAN-KETTERING INST CAN RESEARCH2024–2029
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: